Onward Medical N.V.
ONWRF
$5.70
-$0.42-6.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,548.50% | 1,164.13% | 227.94% | -38.73% | -109.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,548.50% | 1,164.13% | 227.94% | -38.73% | -109.25% |
| Cost of Revenue | -0.85% | -6.59% | -9.37% | -12.41% | -15.34% |
| Gross Profit | 22.25% | 20.95% | 17.87% | 10.06% | 1.51% |
| SG&A Expenses | 25.47% | 17.88% | 13.96% | 7.85% | 1.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.75% | 4.58% | 1.67% | -1.17% | -3.90% |
| Operating Income | -2.46% | 1.12% | 1.72% | -0.21% | -2.30% |
| Income Before Tax | -8.57% | -2.28% | 0.82% | 0.87% | 0.83% |
| Income Tax Expenses | 279.97% | 377.28% | -136.91% | 51.82% | 63.81% |
| Earnings from Continuing Operations | -10.67% | -3.07% | 1.23% | 0.44% | -0.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.67% | -3.07% | 1.23% | 0.44% | -0.44% |
| EBIT | -2.46% | 1.12% | 1.72% | -0.21% | -2.30% |
| EBITDA | -2.21% | 1.49% | 2.22% | 0.26% | -1.92% |
| EPS Basic | 26.36% | 29.02% | 29.34% | 18.22% | 6.44% |
| Normalized Basic EPS | 27.69% | 29.36% | 28.80% | 18.45% | 7.68% |
| EPS Diluted | 26.64% | 29.08% | 29.17% | 18.11% | 6.39% |
| Normalized Diluted EPS | 27.69% | 29.36% | 28.80% | 18.45% | 7.68% |
| Average Basic Shares Outstanding | 53.03% | 50.54% | 47.86% | 27.71% | 7.55% |
| Average Diluted Shares Outstanding | 53.03% | 50.54% | 47.86% | 27.71% | 7.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |